US equities
|
GOOGL
$282.43
▼-13.07%
GOOG
$280.19
▼-12.95%
MSFT
$526.54
▼-0.84%
META
$627.06
▲+2.38%
MU
$932.51
▼-5.16%
NVDA
$212.76
▼-1.22%
AMZN
$244.80
▼-3.85%
AAPL
$349.75
▲+1.72%
GOOGL
$282.43
▼-13.07%
GOOG
$280.19
▼-12.95%
MSFT
$526.54
▼-0.84%
META
$627.06
▲+2.38%
MU
$932.51
▼-5.16%
NVDA
$212.76
▼-1.22%
AMZN
$244.80
▼-3.85%
AAPL
$349.75
▲+1.72%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Myriad Genetics, Inc. - Common Stock
(NQ:
MYGN
)
6.705
+0.075 (+1.13%)
Delayed Quote
Updated: 2:03 PM EDT, Oct 29, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Myriad Genetics, Inc. - Common Stock
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2021
↗
June 15, 2021
Upgrades According to Raymond James, the prior rating for Welltower Inc (NYSE:WELL) was changed from Market Perform to Strong Buy. For the first quarter, Welltower had an...
Via
Benzinga
Recap: Myriad Genetics Q3 Earnings
↗
May 03, 2021
Shares of Myriad Genetics (NASDAQ:MYGN) remained flat in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share rose 25.00% over the past...
Via
Benzinga
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
↗
May 01, 2021
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2021
↗
June 03, 2021
Upgrades According to B of A Securities, the prior rating for Bloom Energy Corp (NYSE:BE) was changed from Underperform to Neutral. For the first quarter, Bloom Energy had...
Via
Benzinga
Myriad Genetics's Earnings Outlook
↗
April 30, 2021
Myriad Genetics (NASDAQ:MYGN) unveils its next round of earnings this Monday, May 03. Here is Benzinga's everything-that-matters guide for the earnings announcement. Net Income,...
Via
Benzinga
The Daily Biotech Pulse: FibroGen Fudges Safety Data, Novartis Strikes Cancer Drug Collaboration, Immutep Gains On Patent Award
↗
April 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 6) AngioDynamics, Inc. (NASDAQ...
Via
Benzinga
Topics
Intellectual Property
70 Biggest Movers From Yesterday
↗
May 06, 2021
Gainers Nemaura Medical Inc. (NASDAQ: NMRD) shares surged 135.3% to close at $11.06 on Wednesday after the company receipt of a purchase order for 5,000 sugarBEAT transmitters...
Via
Benzinga
Earnings Scheduled For May 3, 2021
↗
May 03, 2021
Companies Reporting Before The Bell • Scienjoy Holding (NASDAQ:SJ) is estimated to report quarterly earnings at $0.58 per share on revenue of $540.11 million. •...
Via
Benzinga
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
